Sunesis to Present at Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, CA, Mar 01, 2010 (MARKETWIRE via COMTEX News Network) -- Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced that the Company is schedule to participate in the following events in March:
-- RBC Capital Markets 2010 Healthcare Conference Panel: "Cancer: Improving Treatment through Combination Therapy" Wednesday, March 3, 2010 at 8:00 a.m. Eastern Time at the New York Palace Hotel in New York City; -- Cowen and Company 30th Annual Healthcare Conference Wednesday, March 10, 2010 at 8:45 a.m. Eastern Time at the Boston Marriott Copley Place Hotel in Boston.
Live webcasts of the events will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcasts will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the respective dates of the presentations.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries: Andrea Rabney Argot Partners 212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc. 650-266-3717
SOURCE: Sunesis Pharmaceuticals
Copyright 2010 Marketwire, Inc., All rights reserved.
News Provided by COMTEX